| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Nov 17, 2021 | Buy(P) | 3K | $1.96 | $6K | 24K |
| Nov 17, 2021 | Buy(P) | 400 | $1.93 | $772 | 24K |
| Nov 17, 2021 | Buy(P) | 1K | $1.94 | $3K | 24K |
| Nov 17, 2021 | Buy(P) | 18K | $1.98 | $35K | 24K |
| Nov 17, 2021 | Buy(P) | 1K | $1.97 | $2K | 24K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-141628) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Inhibikase Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.